Abstract
In February 2018, the World Health Organization (WHO) designated "Disease X" as a placeholder for a hypothetical and unidentified pathogen capable of potentially causing an epidemic in the future. The Covid-19 pandemic that unfolded recently has highlighted the emergence of a highly contagious Disease X, serving as a painful reminder of the potential risks we confront. This article aims to explore the emergence of Disease X, its possible origins, and proposes strategies to improve preparedness for such scenarios. Firstly, Disease X is probably a highly infectious zoonotic virus with RNA as its genetic material. Secondly, factors that may contribute to the emergence of the disease, including population density, ecological deterioration, and medical resources. Finally, barriers to the development of antiviral drugs and vaccines are examined, along with recommendations for social and ecological measures to enhance our preparedness for disease X.
Publisher
Darcy & Roy Press Co. Ltd.
Reference58 articles.
1. Adedeji, W.A. (2016) The treasure called antibiotics, Annals of Ibadan postgraduate medicine. U.S. National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354621/ (Accessed: March 19, 2023).
2. Allen, T. et al. (2017) “Global hotspots and correlates of emerging zoonotic diseases,” Nature Communications, 8 (1). Available at: https://doi.org/10.1038/s41467 - 017 - 00923 - 8.
3. Avatt Archives (no date) Africa CDC. Available at: https://africacdc.org/tag/avatt/ (Accessed: March 21, 2023).
4. Baker, R.E. et al. (2021) “Infectious disease in an ERA of global change,” Nature Reviews Microbiology, 20(4), pp. 193–205. Available at: https://doi.org/10.1038/s41579 - 021 - 00639 - z.
5. CGIAR (no date). Available at: https://cgspace.cgiar.org/handle/10568/21161 (Accessed: March 19, 2023).